Literature DB >> 33411779

Testing a mindfulness meditation mobile app for the treatment of sleep-related symptoms in adults with sleep disturbance: A randomized controlled trial.

Jennifer L Huberty1, Jeni Green1, Megan E Puzia2, Linda Larkey3, Breanne Laird1, Ana-Maria Vranceanu4, Robert Vlisides-Henry5, Michael R Irwin6,7.   

Abstract

The objective of this randomized controlled trial was to test whether a commercially available, mindfulness meditation mobile app, (i.e., Calm app), was effective in reducing fatigue (primary outcome), pre-sleep arousal, and daytime sleepiness (secondary outcomes) in adults with sleep disturbance (Insomnia Severity Index Score >10) as compared to a wait-list control group. Associations between the use of the Calm app (i.e., adherence to the intervention) and changes in sleep quality was also explored in the intervention group only. Adults with sleep disturbance were recruited (N = 640). Eligible and consenting participants (N = 263) were randomly assigned to the intervention (n = 124) or a wait-list control (n = 139) group. Intervention participants were asked to meditate using the Calm app ≥10 minutes/day for eight weeks. Fatigue, daytime sleepiness, and pre-sleep arousal were assessed at baseline, mid- (4-weeks) and post-intervention (8-weeks) in both groups, whereas sleep quality was evaluated only in the intervention group. Findings from intent-to-treat analyses suggest the use of the Calm app for eight weeks significantly decreased daytime fatigue (p = .018) as well as daytime sleepiness (p = .003) and cognitive (p = .005) and somatic (p < .001) pre-sleep arousal as compared to the wait-list control group. Within the intervention group, use of the Calm app was associated with improvements in sleep quality (p < .001). This randomized controlled trial demonstrates that the Calm app can be used to treat fatigue, daytime sleepiness, and pre-sleep arousal in adults with sleep disturbance. Given that the Calm app is affordable and widely accessible, these data have implications for community level dissemination of a mobile app to improve sleep-related symptoms associated with sleep disturbance. Trial registration: ClinicalTrials.gov NCT04045275.

Entities:  

Year:  2021        PMID: 33411779      PMCID: PMC7790277          DOI: 10.1371/journal.pone.0244717

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  51 in total

Review 1.  Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age.

Authors:  Michael R Irwin; Jason C Cole; Perry M Nicassio
Journal:  Health Psychol       Date:  2006-01       Impact factor: 4.267

2.  The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.

Authors:  Charles M Morin; Geneviève Belleville; Lynda Bélanger; Hans Ivers
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

3.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

4.  Self-help treatment for insomnia symptoms associated with chronic conditions in older adults: a randomized controlled trial.

Authors:  Kevin Morgan; Pamela Gregory; Maureen Tomeny; Beverley M David; Claire Gascoigne
Journal:  J Am Geriatr Soc       Date:  2012-10-04       Impact factor: 5.562

Review 5.  Mindfulness meditation for insomnia: A meta-analysis of randomized controlled trials.

Authors:  Hong Gong; Chen-Xu Ni; Yun-Zi Liu; Yi Zhang; Wen-Jun Su; Yong-Jie Lian; Wei Peng; Chun-Lei Jiang
Journal:  J Psychosom Res       Date:  2016-07-26       Impact factor: 3.006

6.  Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials.

Authors:  Hui Ling Soh; Roger C Ho; Cyrus S Ho; Wilson W Tam
Journal:  Sleep Med       Date:  2020-08-26       Impact factor: 3.492

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  CBT-I Coach: A Description and Clinician Perceptions of a Mobile App for Cognitive Behavioral Therapy for Insomnia.

Authors:  Eric Kuhn; Brandon J Weiss; Katherine L Taylor; Julia E Hoffman; Kelly M Ramsey; Rachel Manber; Philip Gehrman; Jill J Crowley; Josef I Ruzek; Mickey Trockel
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

9.  Effects of a mindfulness-based intervention on symptoms and signs in chronic heart failure: A feasibility study.

Authors:  Jonna Norman; Michael Fu; Inger Ekman; Lena Björck; Kristin Falk
Journal:  Eur J Cardiovasc Nurs       Date:  2017-06-22       Impact factor: 3.908

Review 10.  Smartphones for smarter delivery of mental health programs: a systematic review.

Authors:  Tara Donker; Katherine Petrie; Judy Proudfoot; Janine Clarke; Mary-Rose Birch; Helen Christensen
Journal:  J Med Internet Res       Date:  2013-11-15       Impact factor: 5.428

View more
  13 in total

1.  Hybrid Delivery of Mindfulness Meditation and Perceived Stress in Pediatric Resident Physicians: A Randomized Clinical Trial of In-Person and Digital Mindfulness Meditation.

Authors:  Denise R Purdie; Myke Federman; Alan Chin; Diana Winston; Brenda Bursch; Richard Olmstead; Yonca Bulut; Michael R Irwin
Journal:  J Clin Psychol Med Settings       Date:  2022-07-01

Review 2.  "Hidden gains"? Measuring the impact of mindfulness-based interventions for people with mild traumatic brain injury: a scoping review.

Authors:  Brenda C Lovette; Millan R Kanaya; Sarah M Bannon; Ana-Maria Vranceanu; Jonathan Greenberg
Journal:  Brain Inj       Date:  2022-08-24       Impact factor: 2.167

Review 3.  Resting and Recharging: A Narrative Review of Strategies to Improve Sleep During Residency Training.

Authors:  Joyce Redinger; Emmad Kabil; Katherine T Forkin; Amanda M Kleiman; Lauren K Dunn
Journal:  J Grad Med Educ       Date:  2022-08

4.  Insomnia as an Unmet Need in Patients With Chronic Hematological Cancer: Protocol for a Randomized Controlled Trial Evaluating a Consumer-Based Meditation App for Treatment of Sleep Disturbance.

Authors:  Jennifer Huberty; Nishat Bhuiyan; Ryan Eckert; Linda Larkey; Megan Petrov; Michael Todd; Ruben Mesa
Journal:  JMIR Res Protoc       Date:  2022-07-01

Review 5.  The Importance of Sleep for People With Chronic Pain: Current Insights and Evidence.

Authors:  Katie Whale; Rachael Gooberman-Hill
Journal:  JBMR Plus       Date:  2022-06-17

6.  Exploring Whether Addictions Counselors Recommend That Their Patients Use Websites, Smartphone Apps, or Other Digital Health Tools to Help Them in Their Recovery: Web-Based Survey.

Authors:  Tyler B Wray
Journal:  JMIR Form Res       Date:  2022-06-20

7.  Targeting Anxiety to Improve Sleep Disturbance: A Randomized Clinical Trial of App-Based Mindfulness Training.

Authors:  May Gao; Alexandra Roy; Alana Deluty; Katherine M Sharkey; Elizabeth A Hoge; Tao Liu; Judson A Brewer
Journal:  Psychosom Med       Date:  2022-04-14       Impact factor: 3.864

8.  A Mobile App for Stress Management in Middle-Aged Men and Women (Calm): Feasibility Randomized Controlled Trial.

Authors:  Breanne Laird; Megan Puzia; Linda Larkey; Diane Ehlers; Jennifer Huberty
Journal:  JMIR Form Res       Date:  2022-05-24

Review 9.  Systematic Review for the Medical Applications of Meditation in Randomized Controlled Trials.

Authors:  Do-Young Kim; Soo-Hwa Hong; Seung-Hyeon Jang; So-Hyeon Park; Jung-Hee Noh; Jung-Mi Seok; Hyun-Jeong Jo; Chang-Gue Son; Eun-Jung Lee
Journal:  Int J Environ Res Public Health       Date:  2022-01-22       Impact factor: 3.390

10.  'Mindfulness Living with Insomnia': an mHealth intervention for individuals with insomnia in China: a study protocol of a randomised controlled trial.

Authors:  Chen Pan; Bingyu Tie; Weichao Yuwen; Xiaoyou Su; Yunlong Deng; Xin Ma; Yan Wu; Yanhui Liao; Luya Kong; Yutao Zhang; Ziwan Li; Qinghua Pan; Qiuping Tang
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.